Quick Action

Manufacturer
Equate | Consumer Product Partners, LLC
Effective date
2024-10-15
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
legacy-cache
Hydrated at
2026-08-01 20:52:18

Label at a glance#

ProductQuick Action
Active ingredientSALICYLIC ACID
Label structure12 sections

Dosage and administration

clean the skin thoroughly before applying this product cover the entire affected area with a thin layer one to three times daily because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 2%

Purpose

OTC - PURPOSE SECTION

Acne medication

use

INDICATIONS & USAGE SECTION

for the treatment of acne

Warnings

WARNINGS SECTION

For external use only

Flammable.  Keep away from fire or flame.

When using this product

OTC - WHEN USING SECTION

  • skin iritation and dryness is more likely to occur if you use another topical acne medication at the same time.  If irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed get medical help or contract a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • clean the skin thoroughly before applying this product
  • cover the entire affected area with a thin layer one to three times daily
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or directed by a doctor
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Other information

OTHER SAFETY INFORMATION

  • keep jar lid tightlty closed
  • store in a cool, dry place at room temperature
  • do not freeze

Inactive ingredients

INACTIVE INGREDIENT SECTION

water, alcohol denat., glycerin, isoceteth-20, sorbitol, sodium hydroxide, fragrance, Lavandula stoechas extract, Helichrysum italicum extract, Cistus monspeliensis extract, disodium EDTA

Questions?

OTC - QUESTIONS SECTION

1-888-287-1915

adversa reacation

ADVERSE REACTIONS SECTION

This product is not manufactured or distributed by Reckitt Benckiser, distributor of Clearasil ULTRA Rapid Action Pads

Satisfaction guaranteed-For Questions or comments or to report an undesired reaction or side effect, please call 1-888-287-1915

Distributed by: Wal-Mart Stores, Inc.,

Bentonville, AR 72716

principal display panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

equate beauty

NDC 49035-666-18

COMPARE TO CLEARASIL ULTRA RAPID ACTION PADS*

QUIK ACTION PADS

Salicylic acid 2% acne treatment

TREAT

Clears blocked pores - a cause of acne breakouts

Dermatologist tested

90 PADS

Made in the USA WITH 90% OR MORE OF PARTS Factory Certified

PARABEN FREE

image descriptionimage description

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49035-66649035-666-18

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
24fe0243-4679-48ba-e063-6394a90afcb673263fd5-ff8c-41a9-ae67-6ce23755197f2024-10-21Warnings, Adverse reactionsExact identifier
spl set id: 73263fd5-ff8c-41a9-ae67-6ce23755197f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.